Newsbot Nachrichten

Central Garden & Pet Company (CENT) M&A Call Transcript

Ohmium ernennt Wasserstoffexperten zum Chief Commercial Officer

NEWARK, Kalifornien, USA, und BANGALORE, Indien--(BUSINESS WIRE)--Ohmium International Inc., ein führender Hersteller von modernen und hocheffizienten modularen Protonenaustauschmembran-Elektrolyseuren (PEM), gab heute die Ernennung von Mark Griffin zum Chief Commercial Officer (CCO) bekannt. Griffin wird die Vertriebs- und Marketingorganisation von Ohmium leiten und das Umsatzwachstum, die Kundenakquise sowie den Ausbau eines globalen Ökosystems aus Projektentwicklern, Industrieunternehmen und

Pre-Markets Fill Holes Left from Fridays Selloff

Cooling off tensions in Iran, Q2 earnings and a new mega-memory chip play out of China buoy markets this morning.

Modine: Strong Data Center Growth Makes The Valuation Justifiable

HOOD Eyes Deeper Push Into Prediction Markets: What Does This Mean?

Robinhood may partner with Crypto.com to expand prediction markets, improve reliability and capture more economics despite regulatory risks.

Steffen Bilger: Neuer Verkehrsminister, alte Probleme

Steffen Bilger von der CDU soll auf Patrick Schnieder folgen und neuer Verkehrsminister werden. Die Aufgaben, die ihm bevorstehen, sind umfangreich und bekannt.

Buy, Hold or Sell Robinhood Stock? Key Insights Ahead of Q2 Earnings

HOOD heads into Q2 earnings with strong trading growth, but weak crypto activity, rising costs and a premium valuation cloud the outlook.

Builders FirstSource Q2 Earnings Ahead: What Should Investors Expect?

BLDR heads into Q2 earnings with sales and margins under pressure as housing weakness offsets acquisition and digital support.

Buy These 3 Sales Growth Stocks With Promising Upside Potential

Crown Holdings, J.B. Hunt and JPMorgan stand out for strong sales growth, solid cash flow and attractive valuation metrics amid a cautious market backdrop.

D-Wave Quantum – Der US-Pionier des Quantencomputings gewinnt AT&T als Großkunden!

D-Wave gewinnt AT&T als Aushängeschild – von einer Stunde auf 15 Sekunden Rechenzeit, das überzeugt. Die Aktie springt vorbörslich 9,3 %, der ganze Quantensektor zieht mit. Aber: Es ist ausdrücklich...

Joule läuft, die Compliance nicht: Was SAP-Kunden jetzt tun müssen

Mit dem Digital Omnibus wurden einige KI-Pflichten verschoben – aber längst nicht alle. Wir klären, was Nutzer von SAPs Joule sofort anpacken müssen.

Selective Insurance: A Buy, But Guidance Requires A Much Better Second Half

ACEA S.p.A. (ACEJF) Q2 2026 Earnings Call Transcript

Trip.com Group Limited (TCOM) Discusses Regulatory Penalty, Antitrust Investigation Outcome and Strategic Response Transcript

Shein geht an die Börse: Der Stoff der Geopolitik

Shein produziert Kleidung, nicht Künstliche Intelligenz. Doch weil ein Großteil der chinesischen Baumwolle aus Xinjiang kommt, geriet das Unternehmen zwischen die amerikanisch-chinesischen Fronten.

Enterprise Products to Report Q2 Earnings: Whats in the Cards?

EPD gears up for second-quarter earnings as higher revenues and stronger segment margins are expected, supported by its fee-based midstream business.

Stocks in Action: FUCHS, AXA, LPKF Laser, Lufthansa und Inditex.

Aktie 1.) FUCHS - Schmierstoff-Hersteller profitiert weiterhin von Vorzieheffekten und hebt Jahresprognose an, Berenberg-Downgrade auf Hold mit Kursziel 41 Euro sorgt für Abgabedruck! Schwächer präsentiert...

LTM und Cognition senken mithilfe von Devin Cyberrisiken im Finanzdienstleistungssektor

SAN FRANCISCO, Kalifornien, USA--(BUSINESS WIRE)--LTM, Business Creativity-Partner für die weltweit größten Unternehmen, gab heute eine strategische Partnerschaft mit Cognition bekannt, dem KI-Labor hinter dem Software Engineering-Agenten Devin. Im Rahmen dieser Partnerschaft hat LTM Devin, den autonomen KI-Ingenieur von Cognition, in BlueVerse TM RightLogic integriert. LTM BlueVerse RightLogic ist ein Framework für die Bewertung von Cybersicherheit und die Absicherung von Risiken, das Unterneh

Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?

Krystal Biotech (KRYS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Matson (MATX) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

Matson (MATX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Lindblad Expeditions (LIND) Report Negative Earnings Next Week? What You Should Know

Lindblad Expeditions (LIND) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Helios Technologies (HLIO) to Report Q2 Results: Wall Street Expects Earnings Growth

Helios Technologies (HLIO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Ono Pharmaceutical Co. (OPHLF) Q1 Earnings Expected to Decline

Ono Pharmaceutical Co. (OPHLF) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

Jazz (JAZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth

TG Therapeutics (TGTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate United Fire Group (UFCS) to Report a Decline in Earnings: What to Look Out for

United Fire (UFCS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Voyager Technologies, Inc. (VOYG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Voyager Technologies, Inc. (VOYG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Vertex (VRTX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Palomar (PLMR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Palomar (PLMR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Douglas Dynamics (PLOW) to Report a Decline in Earnings: What to Look Out for

Douglas Dynamics (PLOW) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?

Palantir Technologies (PLTR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Sportradar Group AG (SRAD) Q2 Earnings Expected to Decline

Sportradar Group (SRAD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Otter Tail (OTTR) to Report a Decline in Earnings: What to Look Out for

Otter Tail (OTTR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Gulfport Energy (GPOR) to Report a Decline in Earnings: What to Look Out for

Gulfport (GPOR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Diamondback Energy (FANG) Reports Next Week: Wall Street Expects Earnings Growth

Diamondback (FANG) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Capital Southwest (CSWC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Capital Southwest (CSWC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out for

BioMarin (BMRN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Crescent Energy (CRGY) Reports Next Week: Wall Street Expects Earnings Growth

Crescent Energy (CRGY) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

W&T Offshore (WTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

W&T (WTI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Allison Transmission (ALSN) Earnings Expected to Grow: Should You Buy?

Allison Transmission (ALSN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Advanced Energy Industries (AEIS) Earnings Expected to Grow: Should You Buy?

Advanced Energy (AEIS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tyson Foods (TSN) Earnings Expected to Grow: Should You Buy?

Tyson (TSN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Williams Companies, Inc. (The) (WMB) Earnings Expected to Grow: Should You Buy?

The Williams Companies (WMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Vitesse Energy (VTS) to Report a Decline in Earnings: What to Look Out for

Vitesse (VTS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TKO Group Holdings (TKO) Earnings Expected to Grow: Should You Buy?

TKO Group (TKO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Oneok Inc. (OKE) Earnings Expected to Grow: Should You Buy?

Oneok (OKE) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Marriott International (MAR) Reports Next Week: Wall Street Expects Earnings Growth

Marriott (MAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: CNA Financial (CNA) Q2 Earnings Expected to Decline

CNA Financial (CNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Clorox (CLX) Q4 Earnings Expected to Decline

Clorox (CLX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Avista (AVA) to Report a Decline in Earnings: What to Look Out for

Avista (AVA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ON Semiconductor Corp. (ON) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

ON Semiconductor Corp. (ON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Heres What Key Metrics Tell Us About Bank of Marin (BMRC) Q2 Earnings

The headline numbers for Bank of Marin (BMRC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

FIX Q2 Earnings Call Highlights Data Center Demand and Capacity

Comfort Systems enters the second half with record backlog, firm data center demand and disciplined modular expansion tied to contracted customer needs.

VZ Q2 Earnings Call Signals Faster Growth From Churn Gains

Verizon raised its 2026 outlook as lower churn, reduced subsidy costs, broadband growth and AI fiber deals strengthen earnings and cash flow.

Gulf Conflict Revives Stagflation Fears: ETFs to Play

Stagflation fears are back as Gulf tensions pushed oil above $100 last week. These ETFs could help investors navigate rising inflation and slowing growth.

SLB Q2 Earnings Call Flags Recovery Path and Deepwater Upside

SLB sees a gradual Middle East recovery, deepwater upside and rising digital demand supporting stronger revenues, margins and cash flow.

NEE Q2 Earnings Call Highlights Power Demand Growth

NextEra Energy highlights surging power demand, a 35.1-GW backlog and data-center hubs while keeping long-term earnings growth targets intact.

AXP Q2 Earnings Call Highlights Reinvestment Strategy

American Express lifts its 2026 revenue growth outlook to 10% while reinvesting operating upside in customers, technology and strategic capabilities.

AT&T: Gewinnsprung und ambitionierte Wachstums-Ziele im High-Speed-Internet-Segment sorgen für Schwung!

Gewinnsprung löst Kaufwelle aus: Der überraschend starke Gewinn von 0,65 USD je Aktie lockt massive Kapitalzuflüsse an und treibt den Kurs unter extremem Volumen um gut 5 % nach oben. Wachstumstreiber...

Porsche: Jede dritte deutsche Stelle fällt weg

Seit Monaten wird verhandelt, jetzt steht fest: Bei Porsche fallen nochmals Tausende Stellen im Raum Stuttgart weg. Dafür macht der Hersteller Zugeständnisse.

Wall Street Analysts Think Nabors (NBR) Could Surge 25.68%: Read This Before Placing a Bet

The mean of analysts price targets for Nabors (NBR) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Heres is How to Trade

The mean of analysts price targets for NovoCure (NVCR) points to a 46.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Think Visteon (VC) Could Surge 31.08%: Read This Before Placing a Bet

The consensus price target hints at a 31.1% upside potential for Visteon (VC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Heres What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.